CJC-1295 (DAC:GRF) (short for drug affinity complex:growth hormone-releasing factor), is a synthetic analogue of growth hormone-releasing hormone (GHRH) (also known as growth hormone-releasing factor (GRF)) and a growth hormone secretagogue (GHS) which was developed by ConjuChem Biotechnologies
The combination of the peptides Ipamorelin and CJC 1295 is effectively used for anti-aging purposes as well as those with inflammatory conditions, disease or people that have low IGF-1 levels.
Find out the benefits of Ipamorelin and CJC 1295 and how they work together to increase the natural production of growth hormone for improved energy, fitness and overall health.
Those who participate in studies for HGHoften are given injections 2 to 3 times daily. This is typically before breakfast, before bed, and post-workout. These test periods can last up to several weeks in order to determine the actual CJC-1295 benefits on test-subjects. They are also meant to mimic as closely as possible, the actual secretion of the hormones.